{{drugbox 
| Watchedfields = changed
| verifiedrevid = 443824001
| IUPAC_name = 2-[4-[3-[2-(trifluoromethyl)-10''H''-phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol
| image = Fluphenazine.svg
| width = 251
| image2 = Fluphenazine-xtal-2012-ball-and-stick.png
| width2 = 280

<!--Clinical data-->
| tradename = Prolixin, Modecate, Moditen others
| Drugs.com = {{drugs.com|monograph|fluphenazine-decanoate}}
| MedlinePlus = a682172
| pregnancy_AU = C
| pregnancy_US = C
| pregnancy_category = 
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = by mouth, [[Intramuscular injection|IM]], depot injection (fluphenazine decanoate)

<!--Pharmacokinetic data-->
| bioavailability = 2.7% (by mouth)
| metabolism = unclear<ref name=AHFS2015/>
| elimination_half-life = IM 15 hours (HCL), 7-10 days (decanoate)<ref name=AHFS2015/>
| excretion = Urine, faeces

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 69-23-8
| ATC_prefix = N05
| ATC_suffix = AB02
| PubChem = 3372
| IUPHAR_ligand = 204
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00623
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3255
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = S79426A41Z
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07977
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 5123
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 726

<!--Chemical data-->
| C=22 | H=26 | F=3 | N=3 | O=1 | S=1
| molecular_weight = 437.523 g/mol
| smiles = FC(F)(F)c2cc1N(c3c(Sc1cc2)cccc3)CCCN4CCN(CCO)CC4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H26F3N3OS/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29/h1-2,4-7,16,29H,3,8-15H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = PLDUPXSUYLZYBN-UHFFFAOYSA-N
}}

<!-- Definition and medical uses -->
'''Fluphenazine''', sold under the brand names '''Prolixin''' among others, is an [[antipsychotic]] medication.<ref name=AHFS2015>{{cite web|title=fluphenazine decanoate|url=http://www.drugs.com/monograph/fluphenazine-decanoate.html|publisher=The American Society of Health-System Pharmacists|accessdate=Dec 1, 2015|deadurl=no|archiveurl=https://web.archive.org/web/20151208191534/http://www.drugs.com/monograph/fluphenazine-decanoate.html|archivedate=2015-12-08|df=}}</ref> It is used in the treatment of chronic [[psychosis|psychoses]] such as [[schizophrenia]],<ref name=AHFS2015/><ref name=TGA>{{cite web|title=Product Information: Modecate (Fluphenazine Decanoate Oily Injection)|work=TGA eBusiness Services|publisher=Bristol-Myers Squibb Australia Pty Ltd|date=1 November 2012|accessdate=9 December 2013|url=https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-02643-3|format=PDF|deadurl=no|archiveurl=https://web.archive.org/web/20170802135209/https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-02643-3|archivedate=2 August 2017|df=}}</ref> and appears to be about equal in effectiveness to low-potency [[antipsychotic]]s like [[chlorpromazine]].<ref>{{cite journal|last1=Tardy|first1=M|last2=Huhn|first2=M|last3=Engel|first3=RR|last4=Leucht|first4=S|title=Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.|journal=The Cochrane database of systematic reviews|date=Aug 3, 2014|volume=8|pages=CD009230|pmid=25087165|doi=10.1002/14651858.CD009230.pub2}}</ref> It is given by mouth, [[intramuscular|injection into a muscle]], or [[subcutaneous injection|just under the skin]].<ref name=AHFS2015/> There is also a long acting injectable version that may last for up to four weeks.<ref name=AHFS2015/>

<!-- Side effects and mechanism -->
Common side effects include [[extrapyramidal symptoms|movement problems]], [[sedation|sleepiness]], [[depression (mood)|depression]] and [[weight gain|increased weight]].<ref name=AHFS2015/> Serious side effects may include [[neuroleptic malignant syndrome]], [[leukopenia|low white blood cell levels]], and the potentially permanent movement disorder [[tardive dyskinesia]].<ref name=AHFS2015/> In older people with psychosis as a result of [[dementia]] it may increase the risk of dying.<ref name=AHFS2015/> It may also increase [[prolactin]] levels which may result in [[galactorrhea|milk production]], [[gynecomastia|enlarged breasts in males]], [[impotence]], and [[amenorrhea|the absence of menstrual periods]].<ref name=AHFS2015/> It is unclear if it is safe for use in [[pregnancy]].<ref name=AHFS2015/> Fluphenazine is a [[typical antipsychotic]] of the [[phenothiazine]] class.<ref name=AHFS2015/> Its mechanism of action is not entirely clear but believed to be related to its ability to [[dopamine antagonist|block dopamine receptors]].<ref name=AHFS2015/>

<!-- History, society, and culture -->
Fluphenazine came into use in 1959.<ref>{{cite book|last1=McPherson|first1=Edwin M.|title=Pharmaceutical Manufacturing Encyclopedia.|date=2007|publisher=Elsevier|location=Burlington|isbn=9780815518563|page=1680|edition=3rd|url=https://books.google.ca/books?id=_J2ti4EkYpkC&pg=PA1680|deadurl=no|archiveurl=https://web.archive.org/web/20151208073154/https://books.google.ca/books?id=_J2ti4EkYpkC&pg=PA1680|archivedate=2015-12-08|df=}}</ref> The injectable form is on the [[World Health Organization's List of Essential Medicines]], the most effective and safe medicines needed in a [[health system]].<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref> It is available as a [[generic medication]].<ref name=AHFS2015/> In the United States the tablets costs between 0.22 and 0.42 USD per day for a typical dose.<ref name=AHFS2015/> The wholesale cost in the [[developing world]] of the long acting form is between 0.20 and 6.20 USD per injection as of 2014.<ref>{{cite web|title=Fluphenazine Decanoate|url=http://mshpriceguide.org/en/single-drug-information/?DMFId=358&searchYear=2014|website=International Drug Price Indicator Guide|accessdate=2 December 2015|deadurl=no|archiveurl=https://web.archive.org/web/20170802125455/http://mshpriceguide.org/en/single-drug-information/?DMFId=358&searchYear=2014|archivedate=2 August 2017|df=}}</ref> It was discontinued in Australia around mid 2017.<ref>{{cite web|title=Fluphenazine - Australian Medicines Handbook|work=Australian Medicines Handbook|place=Adelaide, Australia|publisher=Australian Medicines Handbook Pty Ltd|editor=Rossi, S|date=July 2017|accessdate=8 August 2017|url=https://amhonline.amh.net.au/chapters/chap-18/antipsychotics/fluphenazine}}</ref>

==Veterinary medicine==
In horses, it is sometimes given by injection as an [[anxiolytic|anxiety-relieving medication]], though there are many negative common side effects and it is forbidden by many equestrian competition organizations.<ref>{{Cite web|url=http://www.thehorse.com/articles/28907/effects-of-behavior-modifying-drug-investigated-aaep-2011|title=Effects of Behavior-Modifying Drug Investigated (AAEP 2011)|last=Loving, DVM|first=Nancy S.|date=31 March 2012|website=TheHorse.com|publisher=The Horse Media Group|access-date=13 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20170106203758/http://www.thehorse.com/articles/28907/effects-of-behavior-modifying-drug-investigated-aaep-2011|archivedate=6 January 2017|df=}}</ref>

==References==
{{Reflist}} 

{{Antipsychotics}}
{{Navboxes
| title = [[Pharmacodynamics]]
| titlestyle = background:#ccccff
| list1 = 
{{Dopamine receptor modulators}}
{{Histamine receptor modulators}}
{{Sigma receptor modulators}}
}}
{{Tricyclics}}

[[Category:Alcohols]]
[[Category:Antiemetics]]
[[Category:Dopamine antagonists]]
[[Category:Phenothiazines]]
[[Category:Piperazines]]
[[Category:RTT]]
[[Category:Sigma receptor ligands]]
[[Category:Trifluoromethyl compounds]]
[[Category:Typical antipsychotics]]
[[Category:World Health Organization essential medicines]]